• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with adhd medication names list face a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There aren't enough data on how exposure to ADHD for a long time could affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD uk medication for adhd need to evaluate the benefits of using it versus the risks to the foetus. Physicians do not have the necessary data to give clear guidelines, but they can provide information about benefits and risks that can help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy were not at higher risk of fetal malformations, or structural birth defects. Researchers used a large population-based study of case control to assess the frequency of major structural defects in infants who were born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to ensure that the classification was accurate and to eliminate any bias.

The study of the researchers was not without limitations. The most important issue was that they were not able to differentiate the effects of the medication from the disorder at hand. This limitation makes it difficult to know whether the small differences observed in the exposed groups are due to medication use or comorbidities that cause confusion. In addition the study did not examine long-term offspring outcomes.

The study did show that babies whose mothers had taken adhd medication uk for adults medications during pregnancy were at a slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or cut back on their medications prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These increases did appear to be unrelated to the type of medication used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during early pregnancy could be offset by the greater benefits to both the mother and child of continuing treatment for the woman's disorder. Physicians should discuss this with their patients and, where possible, assist them in developing strategies for improving their coping skills that can lessen the effects of her disorder on her daily functioning and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. Often, these decisions are taken in the absence of any evidence that is clear and definitive regardless, so doctors must weigh what they know about their experiences, the experiences of other doctors, and what the research suggests on the subject and their best medication for adhd judgment for each individual patient.

In particular, the issue of potential risks for the baby can be a challenge. The research on this issue is based on observations rather than controlled studies and many of the findings are conflicting. In addition, most studies limit their analysis to live births, which can underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study presented in this journal club addresses these issues by analyzing data on live and deceased births.

Conclusion A few studies have shown an association between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. The majority of studies show an unintended, or slight negative effect. Therefore an accurate risk-benefit analysis must be conducted in every situation.

For women suffering from ADHD, the decision to stop taking medication can be difficult, if not impossible. In an article recently published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of isolation, and family conflict for patients with ADHD. Furthermore, a loss of medication may affect the ability to complete jobs and drive safely which are essential aspects of a normal life for many people with ADHD.

She recommends women who are uncertain about whether to continue or stop taking medication because of their pregnancy should consider the possibility of educating friends, family members and colleagues about the condition, its impact on daily functioning, and on the advantages types Of adhd medication staying on the current treatment regimen. Educating them can also make the woman feel more comfortable when she is struggling with her decision. It is also worth noting that some drugs can pass through the placenta therefore, if a patient decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug could be transferred to the infant.

Risk of Birth Defects

As the use and abuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases as does the concern about the potential effects of these drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Using two massive data sets researchers were able to analyze more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the researchers discovered that the first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects, such as ventriculoseptal defect (VSD).

The authors of the study could not discover any connection between the use of early medications and congenital anomalies such as facial deformities or club feet. The results are consistent with previous studies that have shown a small but significant increase in the risk of cardiac malformations in women who started taking adhd medication over the counter uk medications prior to the time of pregnancy. The risk increased in the latter part of pregnancy, when a lot of women began to stop taking their medication.

Women who took ADHD medication during the first trimester were more likely need a caesarean, have a low Apgar after delivery, and have a baby who needed breathing assistance after birth. The authors of the study were not able to eliminate bias due to selection because they restricted the study to women without other medical conditions that might have contributed to the findings.

Researchers hope that their research will provide doctors with information when they meet pregnant women. They suggest that although the discussion of the risks and benefits is crucial however, the decision to stop or keep treatment should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors also caution that while discontinuing the medications is an option, Types of adhd medication it isn't an option that is recommended due to the high rate of depression and other mental health problems for women who are expecting or who are recently post-partum. Further, research shows that women who stop taking their medications will have a difficult transitioning to life without them after the baby is born.

Nursing

The responsibilities of a new mother can be overwhelming. Women who suffer from ADHD may face a lot of challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to new routines. Therefore, many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medications pass through breast milk in small quantities, so the risk for nursing infant is very low. The rate of exposure to medication will vary based on the dosage and frequency of administration as well as the time of day. Additionally, different drugs enter the infant's system via the gastrointestinal tract or through breast milk. The impact of these medications on the health of a newborn isn't completely comprehended.

Because of the lack of research, some physicians might be tempted to stop taking stimulant drugs during a woman's pregnancy. This is a difficult choice for the patient, who must balance the benefits of keeping her medication against the potential risks to the foetus. Until more information becomes available, GPs may inquire about pregnant patients whether they have any history of ADHD or if they plan to take medication during the perinatal phase.

A growing number of studies have proven that most women can safely continue to take their ADHD medication during pregnancy and while breastfeeding. In the end, many patients choose to do so and, in consultation with their doctor they have found that the benefits of continuing their current medication outweigh any potential risks.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD recognize their symptoms and the underlying disorder and learn about treatment options and strengthen existing strategies for coping. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include discussion of a management plan for both mother and child, monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.